ORCL
58
2
AME
63
-3
PRU
48
-3
FRT
51
-4
LNC
43
-3
AIZ
68
-5
MCD
50
-12
EW
40
-2
SLB
46
2
VIX
44
-8
AON
32
-4
SWK
68
-3
HBAN
51
-2
HCA
42
3
RRC
76
-2
XEL
55
-2
MHK
46
10
O
37
-2
ROP
59
2
AFL
60
-2
ORCL
58
2
AME
63
-3
PRU
48
-3
FRT
51
-4
LNC
43
-3
AIZ
68
-5
MCD
50
-12
EW
40
-2
SLB
46
2
VIX
44
-8
AON
32
-4
SWK
68
-3
HBAN
51
-2
HCA
42
3
RRC
76
-2
XEL
55
-2
MHK
46
10
O
37
-2
ROP
59
2
AFL
60
-2
Financhill
Back

Altimmune Stock Predictions

9,530x the last time this happened

Here's what our expert says you should buy before April 14.
Sell
41

ALT
Altimmune

Last Price:
7.19
Seasonality Move:
43.42%

7 Day Trial

ALL ACCESS PASS

$ 7

NOW is the time to get in on this trillion-dollar megatrend

Get it here.

Altimmune Stock Forecast

  • Over the next 52 weeks, Altimmune has on average historically risen by 3.6% based on the past 18 years of stock performance.
  • Altimmune has risen higher in 8 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
  • Is Altimmune Stock Undervalued?
    The current Altimmune [ALT] share price is $7.20. The Score for ALT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • ALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Altimmune Stock Go Up Next Year?

  • Over the next 52 weeks, Altimmune has on average historically risen by 3.6% based on the past 18 years of stock performance.

Altimmune Stock Rating

Sell
41
Altimmune (ALT) is a Sell

Is Altimmune overpriced?

  • Altimmune has risen higher in 8 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Altimmune Stock Price History

Is ALT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com

52-Week Data

52-Week High:
14.84
52-Week Low:
2.09

Prediction Charts

Market Cap:
510.45M
Price in USD:
7.20
Volume:
2.31M
Beta:
1.13

Technical Analysis

SMA50:
9.30
SMA100:
9.26
SMA200:
5.99
52-Wk Change:
37.67%

Stock Predictions

  • Is Altimmune stock public?
    Yes, Altimmune is a publicly traded company.
  • What is the Altimmune stock quote today?
    The Altimmune stock price is 7.20 USD today.
  • How to buy Altimmune stock online?
    You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-8 9.09 8.61 9.15 8.55
Apr-9 8.60 8.39 8.71 8.11
Apr-10 8.05 8.01 8.35 7.96
Apr-11 8.07 8.41 8.54 7.96
Apr-12 8.33 7.99 8.33 7.75
Apr-15 7.95 7.55 7.98 7.32
Apr-16 7.42 7.52 7.65 7.23
Apr-17 7.65 7.04 7.65 7.01
Apr-18 6.97 6.90 7.26 6.85
Apr-19 6.85 6.90 7.01 6.64
Apr-22 7.03 7.48 7.55 6.85
Apr-23 7.47 7.57 8.23 7.47
Apr-24 7.55 7.08 7.75 6.98
Apr-25 6.88 7.20 7.25 6.78

Altimmune Earnings

Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.

Altimmune Forecast Revenue Growth

Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.21 per share, a decrease next quarter of $1.16 per share, an increase this year of $0.64 per share, and a decrease next year of $0.20 per share.

* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.